Relationship between degree of deacetylation of chitosan and their water solubility [11].
\r\n\t2) Human sexual disorders in males and females.
\r\n\t3) Psychological aspects of the human sexual response cycle and its disorders.
\r\n\t4) The therapeutic aspects.
\r\n\tThe human sexual response cycle and human sexual behavior are interrelated. How this inter-relationship and its association to normal sexual health need to be delineated. In a world torn between sex and sexually transmitted disease, clear-cut scientific information in the form of a monograph is required to educate.
\r\n\r\n\tHuman sexuality, gender identity, and sexuo-erotic orientation play great roles in human health and disease. Sex education is the need of the hour and a reflection will be timely.
",isbn:"978-1-80355-151-7",printIsbn:"978-1-80355-150-0",pdfIsbn:"978-1-80355-152-4",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,hash:"13af09c4cf93ae89789a3db597972cf6",bookSignature:"Dr. Dhastagir Sultan Sheriff",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11267.jpg",keywords:"Master and Johnson's Cycle, Sex Education, Premature Ejaculation, Orgasmic Disorders, Sexual Aversion Disorders, Dyspareunia, Vaginismus, Sex Hormones, Sexually Transmitted Diseases, Impotence, Low Libido, Blood Analyses",numberOfDownloads:98,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"August 18th 2021",dateEndSecondStepPublish:"March 3rd 2022",dateEndThirdStepPublish:"May 2nd 2022",dateEndFourthStepPublish:"July 21st 2022",dateEndFifthStepPublish:"September 19th 2022",remainingDaysToSecondStep:"3 months",secondStepPassed:!0,currentStepOfPublishingProcess:4,editedByType:null,kuFlag:!1,biosketch:"Dr. Sheriff is a life counselor, sex educationist, and researcher with over 35 years of teaching experience, five authored books, and editorials written in the British Journal of Sexology and the Journal of Royal Society of Medicine. Dr. Sheriff is a life member of the European Society for Human Reproduction, and Early Human Development, American Association of Clinical Chemistry, Association of Physiologists and Pharmacologists of India, and a member of the National Academy of Medical Sciences.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"167875",title:"Dr.",name:"Dhastagir Sultan",middleName:null,surname:"Sheriff",slug:"dhastagir-sultan-sheriff",fullName:"Dhastagir Sultan Sheriff",profilePictureURL:"https://mts.intechopen.com/storage/users/167875/images/system/167875.jpg",biography:"Dhastagir Sultan Sheriff is a life member of the European Society for Human Reproduction and Early Human Development, Association of Physiologists and Pharmacologists of India, member of the National Academy of Medical Sciences, New Delhi, and resource person for UNESCO for Medical and Bioethics. Dr. Sheriff has authored five books including a textbook on medical biochemistry with additional interest in human sexology. He had editorials written in the British Journal of Sexology, Journal of Royal Society of Medicine, Postgraduate Medicine, and Scientist. He was a former Rotarian, Citizen Ambassador, and was selected for the Ford Foundation Fellowship.",institutionString:"University of Benghazi",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"2",institution:{name:"University of Benghazi",institutionURL:null,country:{name:"Libya"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"21",title:"Psychology",slug:"psychology"}],chapters:[{id:"81652",title:"Sexual Health Education for Youth with Disabilities: An Unmet Need",slug:"sexual-health-education-for-youth-with-disabilities-an-unmet-need",totalDownloads:19,totalCrossrefCites:0,authors:[null]},{id:"81518",title:"Narrativity in Becoming Sex/Gender",slug:"narrativity-in-becoming-sex-gender",totalDownloads:11,totalCrossrefCites:0,authors:[null]},{id:"80813",title:"The Biological Basis of Gender Incongruence",slug:"the-biological-basis-of-gender-incongruence",totalDownloads:27,totalCrossrefCites:0,authors:[null]},{id:"80771",title:"The Strangeness and Origins of Human Sexuality",slug:"the-strangeness-and-origins-of-human-sexuality",totalDownloads:42,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"440212",firstName:"Elena",lastName:"Vracaric",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/440212/images/20007_n.jpg",email:"elena@intechopen.com",biography:"As an Author Service Manager, my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6934",title:"Psycho-Social Aspects of Human Sexuality and Ethics",subtitle:null,isOpenForSubmission:!1,hash:"44731b106aa0d1ab5c64a7394483c7d5",slug:"psycho-social-aspects-of-human-sexuality-and-ethics",bookSignature:"Dhastagir Sultan Sheriff",coverURL:"https://cdn.intechopen.com/books/images_new/6934.jpg",editedByType:"Edited by",editors:[{id:"167875",title:"Dr.",name:"Dhastagir Sultan",surname:"Sheriff",slug:"dhastagir-sultan-sheriff",fullName:"Dhastagir Sultan Sheriff"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7163",title:"Infertility, Assisted Reproductive Technologies and Hormone Assays",subtitle:null,isOpenForSubmission:!1,hash:"6db6e4ccb7088f17f819121f7eb6424d",slug:"infertility-assisted-reproductive-technologies-and-hormone-assays",bookSignature:"Dhastagir Sultan Sheriff",coverURL:"https://cdn.intechopen.com/books/images_new/7163.jpg",editedByType:"Edited by",editors:[{id:"167875",title:"Dr.",name:"Dhastagir Sultan",surname:"Sheriff",slug:"dhastagir-sultan-sheriff",fullName:"Dhastagir Sultan Sheriff"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6494",title:"Behavior Analysis",subtitle:null,isOpenForSubmission:!1,hash:"72a81a7163705b2765f9eb0b21dec70e",slug:"behavior-analysis",bookSignature:"Huei-Tse Hou and Carolyn S. Ryan",coverURL:"https://cdn.intechopen.com/books/images_new/6494.jpg",editedByType:"Edited by",editors:[{id:"96493",title:"Prof.",name:"Huei Tse",surname:"Hou",slug:"huei-tse-hou",fullName:"Huei Tse Hou"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9052",title:"Psychoanalysis",subtitle:"A New Overview",isOpenForSubmission:!1,hash:"69cc7a085f5417038f532cf11edee22f",slug:"psychoanalysis-a-new-overview",bookSignature:"Floriana Irtelli, Barbara Marchesi and Federico Durbano",coverURL:"https://cdn.intechopen.com/books/images_new/9052.jpg",editedByType:"Edited by",editors:[{id:"174641",title:"Dr.",name:"Floriana",surname:"Irtelli",slug:"floriana-irtelli",fullName:"Floriana Irtelli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10981",title:"Sport Psychology in Sports, Exercise and Physical Activity",subtitle:null,isOpenForSubmission:!1,hash:"5214c44bdc42978449de0751ca364684",slug:"sport-psychology-in-sports-exercise-and-physical-activity",bookSignature:"Hilde G. Nielsen",coverURL:"https://cdn.intechopen.com/books/images_new/10981.jpg",editedByType:"Edited by",editors:[{id:"158692",title:"Ph.D.",name:"Hilde",surname:"Nielsen",slug:"hilde-nielsen",fullName:"Hilde Nielsen"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10211",title:"The Science of Emotional Intelligence",subtitle:null,isOpenForSubmission:!1,hash:"447fc7884303a10093bc189f4c82dd47",slug:"the-science-of-emotional-intelligence",bookSignature:"Simon George Taukeni",coverURL:"https://cdn.intechopen.com/books/images_new/10211.jpg",editedByType:"Edited by",editors:[{id:"202046",title:"Dr.",name:"Simon George",surname:"Taukeni",slug:"simon-george-taukeni",fullName:"Simon George Taukeni"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7811",title:"Beauty",subtitle:"Cosmetic Science, Cultural Issues and Creative Developments",isOpenForSubmission:!1,hash:"5f6fd59694706550db8dd1082a8e457b",slug:"beauty-cosmetic-science-cultural-issues-and-creative-developments",bookSignature:"Martha Peaslee Levine and Júlia Scherer Santos",coverURL:"https://cdn.intechopen.com/books/images_new/7811.jpg",editedByType:"Edited by",editors:[{id:"186919",title:"Dr.",name:"Martha",surname:"Peaslee Levine",slug:"martha-peaslee-levine",fullName:"Martha Peaslee Levine"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"55483",title:"Amygdala and Emotional Modulation of Multiple Memory Systems",doi:"10.5772/intechopen.69109",slug:"amygdala-and-emotional-modulation-of-multiple-memory-systems",body:'\nThe amygdala of the mammalian brain has been historically associated with emotional behavior (e.g., Ref. [1]), and studies conducted over the past several decades have indicated that this structure also modulates the storage of long-term memories (for review, see Ref. [2]). In particular, the amygdala confers the influence of emotional arousal on learning and memory processes occurring in other brain regions, such as the hippocampus and dorsal striatum [3, 4].
\nWithin the context of a “multiple systems” approach to memory organization, the hippocampus is a critical part of a neural system mediating what are broadly defined as “cognitive” memories involving explicit, declarative information, such as facts and past experiences [5]. Cognitive memory function of the hippocampus also includes acquisition of spatial cognitive maps, i.e., learned mental representations of space which may be used for allocentric navigation [6]. In contrast, the dorsal striatum mediates associations between stimuli and responses and thus encodes memories broadly defined as procedural, stimulus-response (S-R), or habitual (i.e., perseverative responding following devaluation of the reinforcer) [7]. For instance, the dorsolateral striatum (DLS) mediates habitual lever pressing behavior in instrumental learning situations [8], as well as acquisition and expression of a consistently reinforced egocentric turning response in the plus-maze [9].
\nThe hippocampus and dorsal striatum differ not only in terms of their anatomical loci and mnemonic functions, but also these brain regions are differentially influenced by parametric factors, including amount of training, reinforcement schedules, and stress/anxiety [10]. As noted above, the emotional modulation of memory systems is mediated by the amygdala, which becomes active during states of emotional arousal and sends glutamatergic projections to other structures to influence the consolidation of memory [2]. The impact of emotional arousal on memory conferred by the amygdala appears to influence hippocampus- and dorsal striatum-dependent memory differently. For instance, high levels of stress or anxiety typically impair learning and memory functions of the hippocampus and enhance learning and memory functions of the dorsolateral striatum [3, 4].
\nThe present chapter provides an updated review of the emotional modulation of multiple memory systems with a focus on the role of the basolateral amygdala. The review begins by describing evidence for the existence of multiple memory systems in the mammalian brain, and this is followed by a review of the influence of stress and anxiety on hippocampus and dorsal striatum-dependent memory processes. Although emotional arousal potentially influences memory formation in several brain regions, we focus on the hippocampus and dorsal striatum. Potential mechanisms through which the amygdala modulates multiple memory systems are also discussed, including the role of memory system interactions, stress hormones, and synaptic plasticity. The relevance of these findings to understanding and treating some human psychopathologies is also considered.
\nThe mammalian brain is composed of anatomically distinct memory systems [11, 12]. An understanding of the relative contributions of these distinct systems to memory is based upon studies dissociating their involvement in specific memory tasks. Carefully designed behavioral tasks can be used to parse the unique roles of multiple memory systems by keeping sensory, motor, and motivational factors constant, but changing the learning and memory requirements from one task to another. When manipulations of one brain region affect task “A,” but not task “B,” and lesions of another brain region affect task “B,” but not task “A,” we can determine that these two brain systems play distinct and somewhat independent roles in memory processing [12].
\nThe first studies demonstrating a double dissociation between hippocampus- and dorsal striatum-dependent memory systems employed an eight-arm radial maze [13, 14]. Two distinct versions of the eight-arm radial maze were used: a cognitive spatial version and an S-R habit version. In the spatial version (also called the win-shift task), a rat was given the opportunity to explore the maze and retrieve food contained at the end of each arm. Multiple extra-maze cues surrounded the maze, allowing rats to acquire a cognitive map of the learning environment, which they could use to seek the spatial locations containing food and avoid the spatial locations from which food was already retrieved. Rats given lesions to the hippocampal system made more re-entries into the unbaited arms, indicating an impairment in spatially guided memory performance, whereas rats given lesions to the dorsal striatum were not impaired [13, 14].
\nIn the S-R habit version of the radial maze (also called the win-stay version), a light cue at each arm signaled whether food was available there. An error was recorded if the animal entered an arm which was not currently signaled with a light cue. This task involves S-R habit memory to the extent that successful performance requires animals to associate the light cue (S) with approach behavior (R) [15]. Lesion of the dorsal striatum impaired memory performance in this S-R habit version of the radial maze, whereas hippocampal lesions actually enhanced performance [13]. A later study indicated that lesions confined to the dorsolateral striatum (DLS) were sufficient to impair memory in the S-R radial maze [16]. Taken together, these findings indicate that the hippocampus but not the DLS mediates spatial memory, whereas the DLS but not the hippocampus mediates S-R habit memory. Considering that the spatial and S-R versions of the radial maze depend on similar motivational, motoric, and sensory requirements, the differential role of the hippocampus and DLS may be attributed to the distinct mnemonic requirements in each task. The observation that hippocampal lesions
A plus-maze apparatus has also been extensively employed to examine multiple memory systems in rats. The plus-maze consists of four arms arranged in a cross-shaped (+) orientation. Three slightly different procedures can be carried out to dissociate multiple memory systems using the plus-maze. Rats trained in a dual-solution task were released from a consistent start arm (e.g., North arm) with a palatable food reinforcer located in a consistent goal arm (e.g., West arm). Two distinct learning strategies could lead to a food reward: 1) rats could learn the spatial location of the reinforcer and spatially guide behavior to the reinforced location or 2) rats could acquire a consistent body-turn response at the intersection of the maze (e.g., turn right), regardless of the spatial location of the reinforcer. The strategy was assayed using a subsequent probe trial in which the animal was released from the opposite starting position (e.g., South arm). If rats went to the same spatial location (i.e., making the opposite turn at the choice point), they were identified as place learners. If rats continued to make the same turn at the maze intersection as they did during training, they were identified as response learners.
\nOne of the interesting features of the dual-solution plus-maze task is that early in training animals usually display place learning during the probe trial, whereas after extended training, animals predominantly display response learning, potentially indicating the gradual formation of a motor habit [9, 17, 18]. In addition to the training parameters, the expression of place and response learning may also be influenced following temporary inactivation of the hippocampus or DLS. Early in training, when control animals displayed place learning, temporary inactivation of the hippocampus before the probe trial eliminated preferential use of either place or response learning, whereas DLS inactivation had no effect [9]. Later in training, when control animals mostly displayed response learning, temporary inactivation of the DLS before the probe trial shifted animals back to the predominant use of place learning, whereas hippocampal inactivation had no effect [9].
\nThe role of the hippocampus in place learning and DLS in response learning has also been demonstrated using single-solution versions of the plus-maze. In a place learning version of the plus-maze, animals are released from alternating start arms (e.g., North and South), whereas the food reinforcer remains in a consistent spatial location (e.g., the West arm). Thus, in order for animals to be successful in this task, they presumably need to acquire a spatial cognitive map of the learning environment using extra-maze cues so that they may accurately guide behavior from different starting positions to the same spatial location. In the response learning version of the plus-maze, the animal is reinforced to make a consistent body-turn response (e.g., right turn) at the maze intersection, regardless of the animal’s starting position. For instance, if the animal is started from the North arm, the food reward may be located in the West arm; if the animal is started from the South arm, the food reward is located in the East arm. In this particular example, regardless of the animal’s starting position, a right body-turn will consistently lead to the reinforcer. Extensive evidence using these tasks indicates that learning and memory in the place version of the plus-maze requires hippocampal function, whereas learning and memory in the response version requires DLS function [19–22].
\nThe radial maze and plus-maze experiments, as well as other experiments using a Morris water maze [23–25], have been critical in demonstrating the differential mnemonic functions of the hippocampus and DLS. These studies have provided strong converging evidence that the hippocampus mediates spatial cognitive memory, whereas the DLS mediates S-R habit memory. Additional studies have been conducted primarily using the plus-maze tasks to demonstrate that these different kinds of memory are differentially influenced by parametric factors, such as exposure to stress and anxiety [4, 10, 26].
\nThe influence of emotion on memory has been well known since ancient times. The
Extensive experimental evidence from rodents and humans indicates that emotional arousal modulates hippocampus- and DLS-dependent forms of memory differently. In an initial demonstration of the emotional modulation of multiple memory systems, investigators employed two versions of the Morris water maze, a spatial version dependent on hippocampal function and a cued version dependent on DLS function. In the spatial version, animals were released into a large circular pool of water over the course of training from multiple starting positions. In order to escape the water, the animals could mount an invisible escape platform located in a consistent spatial location. Thus, learning to quickly find the platform over the course of training may require acquisition of a cognitive map of the learning environment. In the cued version of the Morris water maze, animals were also released from different starting positions, however the platform remained visible throughout training, enabling animals to form an S-R association between the visibly cued platform (S) and swimming approach behavior (R). Evidence indicates that spatial learning in the Morris water maze depends on hippocampal function [27], whereas cued learning depends on dorsal striatal function [24, 25, 28–30].
\nConsistent with the hypothesis that emotion differentially influences multiple memory systems, a stress regimen involving chronic restraint and tail shock impairs memory in the hippocampus-dependent spatial version of the Morris water maze, but enhances memory in the DLS-dependent cued version [31]. Similarly, in a dual-solution version of the plus-maze, a chronic variable stress regimen that includes chronic restraint and forced swim among other potent stressors leads to the preferential use of response learning over place learning during the probe trial [32]. This chronic variable stress regimen is also associated with increased changes in dendritic morphology in the DLS [32]. In a circular hole-board task that can also be solved adequately using either a place strategy or S-R strategy, chronic restraint stress also increases the use of an S-R strategy [33].
\nThe effects of chronic stress regimens on memory systems may also be observed with acute behavioral stressors. One hour of restraint stress is sufficient to impair acquisition in a place learning version of the plus-maze and enhance acquisition in a response learning version of the plus-maze [34]. Acute restraint stress is also associated with an increase in the use of a response learning strategy in the circular hole-board task [35]. Similar effects may be observed with an ecologically valid stressor. Pre-training exposure to predator odor enhances acquisition of response learning in a plus-maze task and leads to the preferential use of response learning in a dual-solution version of the plus-maze [36]. Aside from acute or chronic behavioral stressors, hypertension and trait anxiety have also been associated with the use of a response learning strategy in dual-solution versions of the plus-maze and Morris water maze [37–40].
\nThe majority of studies using chronic or acute behavioral stressors have employed procedures with an innate ability to induce emotional arousal (e.g., restraint stress, exposure to predator odor, etc.). However, some studies have also indicated that a previously neutral stimulus that has acquired the ability to induce emotional arousal can also modulate memory. In these studies, animals are initially trained in a standard fear conditioning paradigm, in which a tone is repeatedly paired with a footshock, encouraging the acquisition of a tone-shock association. Later, when the tone is played alone, the animal demonstrates freezing behavior, indicating emotional arousal or, more specifically, fear to the tone. Post-training exposure to a tone previously paired with shock enhances consolidation of response learning in the plus-maze and produces a response learning bias in a dual-solution version of the task [41, 42]. In addition, exposure to a fear-conditioned tone is also associated with greater response learning over place learning in a dual-solution version of the Morris water maze [43].
\nThe influence of behavioral stressors on multiple memory systems is mimicked by anxiogenic drugs. Systemic administration of anxiogenic α-2 adrenoreceptor antagonists yohimbine or RS 79948-197 produces a response learning bias in the dual-solution plus-maze [44, 45]. In addition, systemic administration of RS 79948-197 enhances memory in a response learning task and impairs memory in a place learning task [46, 47]. Administration of the stress hormone corticosterone also enhances response learning in the plus-maze and increases the use of response learning in a circular hole-board task [35, 48]; see also Ref. [34].
\nThus, robust emotional arousal induced by behavioral stressors or anxiogenic drug injections appears to favor DLS-dependent S-R habit memory, while impairing hippocampus-dependent cognitive memory. It should be noted, however, that there is also evidence that emotional arousal may sometimes facilitate hippocampus-dependent memory (for review, see Ref. [2]). It is possible that the influence of emotional arousal on hippocampus-dependent memory follows an inverted U-shaped curve, in which high and low levels of emotional arousal impair and moderate levels enhance cognitive memory [49–51].
\nThe majority of studies examining the influence of emotional arousal on multiple memory systems have employed lower animals, such as rats and mice. However, there is also evidence that emotional arousal may influence human memory in a similar manner. In one experiment, participants were instructed to select one of four cards, which were positioned face-down in a 3-D model of a room, with the goal of picking the “win card.” During training, the win card remained in the same spatial location relative to the distal room cues and was also consistently located next to a proximal cue (i.e., a potted plant). During a subsequent probe trial, the plant was moved to a different spatial location. If participants selected the card next to the plant, they were considered to be using an S-R strategy. If participants selected the card from the original spatial location, they were considered to be using a place strategy. Pre-training psychosocial stress (i.e., public speaking) increased the use of an S-R strategy [52]. Likewise, in a 2-D version of the win-card task, chronic stress was associated with greater use of a response learning strategy over a place learning strategy [33].
\nThe finding that stress and anxiety enhance dorsal striatum-dependent, S-R habit memory has also been observed using an instrumental learning task. Subjects were first trained to perform two instrumental responses, each resulting in the delivery of a distinct food outcome. Later, one of the food outcomes was devalued by freely providing the participant with the food until satiety. Participants subjected to the socially evaluated cold pressor test, which promotes high levels of emotional arousal, continued to make the instrumental response for the devalued outcome, indicating habitual behavior, whereas control subjects decreased responding for the devalued outcome, indicating goal-directed behavior [53, 54].
\nAnother task employed to examine the influence of emotional arousal on multiple memory systems is the probabilistic classification task, also known as the weather prediction task. This task involves presenting participants with a random series of cards covertly associated with distinct weather outcomes (rain or sunshine), and the participant is instructed to predict the weather based on the cards presented for a given trial. Over the course of training, participants are provided with trial-by-trial feedback indicating whether their prediction was correct, allowing participants to gradually learn what series of cards are most likely associated with rain or sunshine. Neuroimaging evidence suggests that either the hippocampus or dorsal striatum may be recruited for learning in this task [55–58], and the relative use of these systems may also be determined behaviorally using mathematical models [59–61]. Emotional arousal elicited using the socially evaluated cold pressor test biases subjects toward the use of a dorsal striatum-dependent strategy in the weather prediction task, whereas non-stressed control subjects show a preference for using a hippocampus-dependent strategy [61]. Moreover, functional magnetic residence imaging (fMRI) indicates that performance in this task is positively correlated with dorsal striatal activation in stressed subjects, whereas performance is positively correlated with hippocampal activation in non-stressed subjects [61].
\nThus, converging evidence from humans and lower animals indicates that high levels of emotional arousal, in particular stress and anxiety, promote a shift from hippocampus-dependent cognitive strategies toward dorsal striatum-dependent habit strategies. The following sections consider some of the mechanisms that may be implicated, including a modulatory role of the amygdala, competition between memory systems, stress hormones, and plasticity.
\nEarly evidence indicated a clear role for the amygdala in learning and memory [1, 62, 63]; however, it took several decades of subsequent research before this brain region was considered one of the principal learning and memory structures of the brain (for review, see Ref. [2]). As mentioned above, the amygdala mediates emotional memories, such as stimulus-affect associations and emotionally charged CS-US associations underlying Pavlovian fear conditioning [64]. In addition to mediating emotional memories, the amygdala also has a prominent role in allowing emotional arousal to influence memory formation in other brain regions, such as the hippocampus and dorsal striatum. Presumably, during high levels of emotional arousal, the amygdala becomes active and modulates memory function of other brain regions either directly through glutamatergic projections to these brain regions or indirectly through activation of the hypothalamic-pituitary-adrenal (HPA) axis, which in turn leads to the release of adrenal stress hormones that directly stimulate memory structures of the brain [2].
\nConsistent with the view that the amygdala confers the effects of emotional arousal on memory, there is extensive evidence that the influence of stress and anxiety on hippocampus- and DLS-dependent memory depends on amygdala function. In one study, animals with amygdala lesions or sham lesions were subjected to chronic restraint/tail shock stress and were subsequently trained in a hippocampus-dependent version of the Morris water maze [31]. Stressed animals with sham lesions showed impaired hippocampus-dependent memory, relative to non-stressed controls, whereas stressed animals with amygdala lesions were not impaired. Thus, the impairing effect of emotional arousal on hippocampal memory function depends on the integrity of the amygdala.
\nWhereas the study cited above employed permanent lesions of the amygdala, similar effects may be observed with temporary inactivation of the basolateral portion of the amygdala (BLA). In one study, animals were trained in either a hippocampus-dependent place learning or DLS-dependent response learning version of the water plus-maze and received post-training systemic infusions of the anxiogenic drug RS 79948-197 [46]. Post-training drug infusions target the consolidation phase of memory processing, i.e., when the short-term memory is consolidated into a long-term memory trace [65]. Post-training anxiogenic drug infusions impaired consolidation in the place learning task and enhanced consolidation in the response learning task, and both of these effects were blocked by temporary inactivation of the BLA with the sodium channel blocker bupivacaine [46]. Likewise, in the dual-solution plus-maze task, exposure to predator odor biased animals toward the use of response learning over place learning, whereas temporary inactivation of the BLA with bupivacaine eliminated the response learning bias produced by predator odor [36].
\nAdditional evidence implicating a role for the amygdala in the emotional modulation of multiple memory systems comes from studies employing intra-BLA administration of anxiogenic drugs. Administration of the anxiogenic drugs RS 79948-197 or yohimbine directly into the BLA mimics the effects of systemic administrations. In a dual-solution plus-maze task, intra-BLA administration of RS 79948-197 or yohimbine leads to the preferential use of response learning over place learning [44, 45]. In addition, intra-BLA administration of RS 79948-197 enhances memory in the response learning version of the plus-maze and impairs memory in the place learning version of the task [66].
\nFinally, the critical role of the amygdala in the emotional modulation of multiple memory systems has also been demonstrated in humans. In one study, human participants were subjected to the socially evaluated cold pressor test, which stimulates emotional arousal, and subsequently performed the weather prediction task while undergoing fMRI [67]. Stressed subjects, relative to non-stressed controls, were more likely to use habit-based strategies over cognitive strategies, and this was accompanied by increased activation of the dorsal striatum and decreased activation of the hippocampus [67]. In addition, stressed subjects showed increased functional connectivity between the amygdala and dorsal striatum and decreased connectivity between the amygdala and hippocampus, relative to non-stressed control subjects [67]. Thus, the amygdala appears to be implicated in the emotional modulation of multiple memory systems in both lower animals and human subjects.
\nThe studies reviewed above clearly indicate that the amygdala, in particular the basolateral complex of the amygdala, is critically implicated in the emotional modulation of hippocampus and DLS-dependent memory. However, the potential mechanisms through which the BLA modulates these systems have yet to be adequately addressed in this chapter. One possibility, as mentioned briefly above, is that the BLA modulates memory through direct glutamatergic projections to other brain regions. Indeed, the BLA strongly innervates the hippocampus [68], making it possible that a direct BLA-hippocampus pathway underlies the influence of emotional arousal on cognitive spatial memory. In contrast, the BLA does not innervate the dorsolateral region of the striatum implicated in habit memory. It is possible that the BLA could modulate DLS-dependent memory through its projections to the posteroventral region [69, 70], which may also be associated with habit memory function [29, 30]. In addition, the BLA projects to the ventromedial region of the striatum, which could possibly influence the DLS indirectly through an ascending spiral (see Ref. [71]). However, the potential roles of these amygdalostriatal projections in the emotional modulation of habit memory have yet to be explored.
\nRegarding the mechanisms that potentially underlie amygdala modulation of memory systems, evidence has indicated a role of stress hormones and competitive interactions between memory systems. There is also evidence that the amygdala may directly modulate synaptic plasticity in the hippocampus, which may be a neural mechanism underlying the emotional modulation of spatial memory.
\nThe influence of emotional arousal on memory formation has been attributed in part to stress hormones, including catecholamines (e.g., noradrenaline) and glucocorticoids (corticosterone in rodents; cortisol in humans). During an emotionally arousing event, stress hormones released via the HPA axis may influence memory by stimulating noradrenergic, glucocorticoid, or mineralocorticoid receptors in the brain [2, 72]. Following release from the periphery, corticosterone readily crosses the blood brain barrier and thus may modulate brain function directly. In contrast, adrenaline cannot cross the blood brain barrier and instead influences brain function by activating the vagus nerve, which enters the brain and innervates the nucleus of the solitary tract [73]. The nucleus of the solitary tract then projects to the locus coeruleus, which releases noradrenaline in multiple brain areas, including the amygdala [74].
\nConsistent with a potential role of stress hormones in the emotional modulation of memory, the effects of stress/anxiety on hippocampus- and DLS-dependent memory may be mimicked following systemic or intra-cerebral injections of drugs that increase stress hormone activity [44, 66, 75–78]. For instance, as mentioned above, systemic or intra-BLA injection of α2-adrenoreceptor antagonist RS 79948-197, which increases noradrenaline release, leads to an enhancement of DLS-dependent habit memory and impairment of hippocampus-dependent spatial memory [44–47, 66]. In addition, systemic or intra-DLS glucocorticoid administration enhances habit memory [48, 77–82; but, see also Ref. 83], whereas systemic or intra-hippocampal glucocorticoids may either enhance or impair cognitive memory [75, 76, 84, 85].
\nThe influence of emotional arousal on hippocampus- and DLS-dependent memory may be prevented via blockade of noradrenergic, glucocorticoid, or mineralocorticoid receptors [35, 67, 86–88]. For instance, the enhancement of DLS-dependent habit memory produced by exposure to a fear conditioned stimulus may be blocked by systemic or intra-BLA administration of the β2-adrenoreceptor antagonist propranolol [42].
\nEvidence suggests that glucocorticoid and noradrenergic mechanisms also interact to influence memory. The enhancing and impairing effects of intra-hippocampal glucocorticoids on cognitive memory depend on noradrenergic activity in the BLA [89, 90]. In addition, whereas systemic corticosterone administration enhances DLS-dependent habit memory in the water plus-maze, this enhancement is blocked by concurrent administration of propranolol [48].
\nIt is possible that both glucocorticoid and noradrenergic mechanisms must be onboard in order for emotional arousal to influence memory. Whereas concurrent administration of hydrocortisone and α2-adrenoreceptor antagonist yohimbine enhances DLS-dependent habit memory, administration of either drug alone has no effect [91]. This seems to contradict other evidence reviewed above suggesting that administration of either corticosterone or RS 79948-197 alone may enhance habit memory in the water plus-maze. However, it is possible that the aversive nature of the water maze may be sufficient to promote the endogenous release of glucocorticoids and noradrenaline in the brain, and since both stress hormones are onboard, subsequent administration of either corticosterone or RS 79948-197 alone may be capable of influencing memory. Indeed, previous evidence indicates that corticosterone administration may only be capable of modulating object recognition memory when the learning situation is sufficiently arousing and thus increases noradrenergic activity in the BLA [92].
\nIn addition to the role of stress hormones, there is also evidence that following BLA modulation of memory systems, the hippocampus and DLS potentially interact with each other in a competitive fashion to influence memory. Competition between two memory systems becomes evident when disrupting function of one memory system enhances function of the other system [57]. For instance, in some learning situations, lesions or temporary inactivation of the hippocampal system enhances memory in DLS-dependent habit memory tasks [13, 14, 93]. Likewise, disrupting dorsal striatal function facilitates memory in some hippocampus-dependent spatial memory tasks [94–96]. Moreover, consistent with a competitive interaction between memory systems, enhancing the function of one system through intra-cerebral injection of memory enhancing drugs sometimes impairs function of the other memory system. For instance, hippocampus-dependent spatial memory is impaired following intra-DLS administration of either glucose or a drug that increases CREB activity [28, 97].
\nSome investigators have suggested that the influence of emotional arousal on multiple memory systems may be partially explained by a competitive interaction between systems [10, 26]. As reviewed above, there is evidence that very high levels of emotional arousal impair hippocampus-dependent spatial memory. Consistent with a competitive interaction between memory systems, this stress-induced impairment of hippocampus-dependent memory may be similar to a hippocampal lesion, to the extent that it may indirectly enhance DLS-dependent habit memory. Indeed, the same anxiogenic drug doses that impair hippocampus-dependent place learning also enhance DLS-dependent response learning in the water plus-maze [34, 46, 66].
\nOn the other hand, it is possible that stress or anxiety may indirectly impair hippocampus-dependent memory in part by increasing dorsal striatal function. As mentioned above, intra-DLS administration of corticosterone facilitates DLS-dependent habit memory. This suggests that stress hormones released following activation of the HPA axis may be able to directly enhance DLS-dependent habit memory through stimulation of dorsal striatal glucocorticoid receptors. Consistent with evidence that in some learning situations, augmenting dorsal striatal function indirectly impairs hippocampus-dependent spatial memory [28, 97], it is possible that an increase in dorsal striatal memory function is partially responsible for the impairment in hippocampus-dependent memory observed following stress or anxiety. This hypothesis has yet to be examined. Likewise, the precise neural mechanisms that mediate competition between memory systems have not been elucidated.
\nThere is evidence to suggest that the emotional modulation of memory may be partially attributed to BLA efferents altering synaptic plasticity in multiple memory systems. Synaptic plasticity refers to experience-dependent changes in brain function and is often considered as a candidate neural substrate of learning and memory [98–101]. BLA stimulation may either enhance or impair long-term potentiation (LTP) in the hippocampus [102], a form of plasticity associated with spatial memory formation (for review, see Ref. [100]). Chronic restraint and tail shock have also been associated with impaired LTP in the hippocampus, and this impairment was blocked by amygdala lesions [31]. In the same study, the stress-induced impairment of hippocampal LTP mediated by the amygdala was also associated with impaired spatial memory and enhanced DLS-dependent memory in the water maze [31].
\nIn addition to modulating hippocampal plasticity, BLA stimulation also facilitates induction of LTP in the ventral striatum [103]. Whether BLA facilitation of ventral striatal plasticity indirectly influences memory function of the dorsal striatum has not been examined.
\nAmygdala modulation of multiple memory systems may be relevant to understanding the role of learning and memory processes in some human psychopathologies. Dorsal striatum-dependent memory processes have been linked to the habit-like behavioral symptoms in numerous psychiatric disorders, such as Tourette syndrome, post-traumatic stress disorder (PTSD), autism spectrum disorders, obsessive-compulsive disorder, drug addiction and relapse, and others [104–109]. Interestingly, stress and anxiety may have an important role in each of these disorders by promoting development, expression, or exacerbation of habit-like symptoms. For instance, one of the characteristic symptoms of PTSD involves avoidance behaviors, which are automatically evoked by trauma-related cues (e.g., jumping away from a loud noise). Some investigators have suggested that such symptoms may reflect heightened DLS-dependent habit memory due to the high levels of emotional arousal during and after the traumatic event [3, 110, 111]. Indeed, neuroimaging evidence indicates differences in amygdala and dorsal striatal structure and function, as well as malformation of the hippocampus and impaired cognitive memory, in individuals with PTSD (for review, see Ref. [110]). Drug abuse may also be viewed as a manifestation of overactive habit memory, which may be exacerbated by stress [109]. In light of evidence in lower animals discussed above, it is likely that the stress-induced enhancement of habit-like symptoms in PTSD, drug addiction, and other disorders may be partially mediated by the amygdala and its connections to multiple memory systems.
\nEmotional arousal induced by stress and anxiety influences distinct memory systems in different ways. Behavioral and pharmacological stressors enhance S-R habit memory mediated by the DLS and impair cognitive spatial memory mediated by the hippocampus in both lower animals and humans. The BLA is the chief neural substrate implicated in the emotional modulation of hippocampus- and DLS-dependent memory. The BLA potentially influences spatial memory via its glutamatergic projections to the hippocampus and also alters synaptic plasticity in this brain region. Stress hormones (i.e., adrenaline and corticosterone/cortisol) are also involved in the emotional modulation of memory via activation of noradrenergic, glucocorticoid, and mineralocorticoid receptors across the BLA, hippocampus, and DLS. The BLA may also influence memory via modulating the competitive interaction between hippocampus- and DLS-dependent memory systems. These experimental findings may provide insight into the neural mechanisms underlying some clinical psychiatric disorders in which high levels of stress or anxiety are associated with impaired cognitive memory and enhanced habit-like symptoms.
\nThe extent of drug bioavailability has been shown to be influenced by the route of drug administration. Oral drug route needs travelling through the continuous passageway of the GIT, which makes them susceptible to the harsh environment of GIT. Drugs intended for administration via this route can be formulated in a variety of dosage forms, such as tablets, capsules, solutions, and powders.
Due to its high patient compliance and ease of administration, the oral route of administration is preferred among other routes. Self-administration is possible with great compliance and reduced risk in developing systemic side effects, which is the major concern in the parenteral route [1]. Despite that, the oral delivery system approaches for certain drugs are challenging, especially the delivery of peptide drugs and vaccines [2].
The normal physiological functions of GIT are to digest food and to interfere with pathogen entry. These functions need to be considered as peptide drugs and vaccines tend to be digested together with food in the presence of digestive enzymes. The highly acidic pH in the stomach and the presence of proteolytic enzymes such as protease and pepsin can cause protein degradation [1].
Furthermore, they will have difficulties in permeating the physical barrier of the mucus lining, which prevents pathogenic substances from penetrating the cell [3]. Owing to these challenges, protein and peptide drugs are suitable to be administered via parenteral routes such as intravenous or subcutaneous injection [4]. However, these routes require frequent administration with long-term use which will develop patient incompliance to medication [4]. In such a manner, the approach to improve the oral delivery of peptide drugs and vaccines by using suitable polymers are needed to enhance drug effectiveness and patient compliance.
Chitin is the second most abundant polysaccharide present in nature. However, it has more applications when converted to chitosan by partial deacetylation under alkaline conditions [5]. Chitosan is a positively charged polymer that can improve the bioavailability of the oral drug delivery system. It has been used to improve the formulation of peptide drugs, resulting in enhanced cell permeability, which allows an adequate therapeutic concentration of drugs into the systemic circulation [6].
For protein and peptide therapeutics, factors such as poor permeability, luminal, brush border, cytosolic metabolism, and hepatic clearance mechanisms result in their poor bioavailability from oral and non-oral mucosal routes [7]. Oral vaccination is prone to reduce the adequacy of vaccine to be recognised by the immune system due to the presence of gut microbiota and intestinal barrier. Peptide drugs and vaccines can be protected from the degradative barrier of the GIT by encapsulating the drugs into the polymeric chitosan as potential carrier material. The development of nanotechnology, such as nanoparticle systems to transport peptide drugs through the epithelial membrane has been established [6, 8]. Besides, the modification of chitosan is needed to exert its function as a polymer and to protect the drug from enzymatic degradation [9].
This work reviews the physicochemical properties and numerous applications of chitosan, describes its release mechanisms, challenges in oral peptides and vaccines delivery, and strategies to overcome these barriers to improve oral peptides and vaccines bioavailability.
Chitosan is a strong base with linear polysaccharides consisting of D-glucosamine, which contains amino groups [10]. The hydrolysis of chitin will produce chitosan through alkaline hydrolysis or N-deacetylation (Figure 1). Due to protonable amino groups presence in chitosan, this polymer can be easily dissolved in pH below 6.3. However, both chitosan and chitin are insoluble in an aqueous medium.
The N-deacetylation of chitin into chitosan.
Chitin or chitosan is highly available from different species of shrimps, prawns and crabs. These seafood shells release chitosan, which shows properties of antimicrobial and antioxidant activity.
One of the differences between chitosan and chitin is the presence of amino groups. Amino group in chitosan exhibits high solubility in acidic medium and able to form complexes with metal ions. These positive charges interact with drugs and physiological barriers in the GIT, which is useful in the formulation design of the drug delivery system [9].
Some factors affect chitosan properties, including the degree of deacetylation, degree of substitution, and molecular weight [9, 11]. These factors should be considered before using chitosan as a polymer in a drug delivery system. Most of the chitosan applications are affected by these factors through intermolecular or intramolecular hydrogen bonds [12].
The degree of chitosan deacetylation will affect its biological activity, including swelling rate, molecular weight, crystallinity and polydispersity. The deacetylation process leads to the protonation of the amino groups [13]. A highly positive charge will improve the activity of chitosan as mucoadhesive permeation enhancing [14] and haemostatic agent [15]. Sometimes, the degree of deacetylation can be used to estimate the water solubility of chitosan [11] as shown in Table 1.
The degree of deacetylation can influence the particle size and molecular weight of chitosan [13]. The removal of the acetyl group in the structure of chitosan or chitin from deacetylation reduces the interaction between molecules. A low number of acetyl groups minimises the chain length, thus reducing the molecular weight of the polymer [16].
The molecular weight of the polymer will influence the degree of swelling [17]. High molecular weight chitosan (HMWC) tends to have a higher cross-linking ability. Therefore, the drug-coated with HMWC tends to release more slowly [18]. This characteristic is favourable in sustained-release oral drug delivery.
Degree of deacetylation | Level | Water solubility |
---|---|---|
55–70% | Low | Completely insoluble |
70–85% | Middle | Partly dissolved |
85–95% | High | Good solubility |
95–100% | Ultrahigh | Completely soluble |
Relationship between degree of deacetylation of chitosan and their water solubility [11].
Generally, the lower the molecular weight, the higher solubility of chitosan is obtained [13, 19]. HMWC appears in α-chitin crystalline or antiparallel structure. The structure forms after the release of water, which leads to the loss of entropy during aggregation of the polymeric chain [13]. This phenomenon results in the loss of Gibbs free energy. Gibbs free energy (G) is a way to predict the amount of usable energy in the system. Loss of energy means the reaction in the system tends to be spontaneous.
The α-chitin crystalline form exhibit lower water solubility as compared to β-chitin. The shorter polymeric chain of low molecular weight chitosan (LMWC) is unlikely to aggregate [11]. Interaction between molecules declines due to the formation of the hydrogen bonds is limited. A short chitosan chain contains a low number of amino groups [20].
Chitin exists in three different polymorphic forms, which are α-chitin, β-chitin, and γ-chitin (Figure 2). The interaction between C═O⋯NH and C═O⋯OH maintaining the strength of the polymeric network chain [13]. α-chitin appears in its antiparallel structure and the chain is interacting through both inter-and intramolecular hydrogen bond. β-chitin has a parallel structure, which leads to the formation of the intramolecular hydrogen bond. γ-chitin consists of both antiparallel and parallel structure, as it is the combination of α-chitin and β-chitin [21].
The different conformational structure between α-chitin, β-chitin and γ-chitin (adapted from [
β-Chitin exhibits better water solubility but less common as compared to α-chitin [14]. It has been shown that α-chitosan has a higher crystallinity index as compared to β-chitin. However, the crystallinity index for both forms is lower than the raw chitosan [21]. The crystallinity index will increase when the degree of deacetylation of chitosan increases [16].
The β-chitin has a high affinity to the organic solvent due to its structural flexibility [14]. It exhibits higher reactivity than α-chitosan due to a lack of hydrogen bond. This form has a high capability to swell between crystalline structures while losing its crystalline fraction [21]. The swelling of β-chitin sometimes disrupts the polymeric chain and crystalline structure.
The particle size of chitosan plays a major role in developing an efficient carrier for peptide drugs [22]. Monodisperse preparation of nanoparticles is desirable to provide better bioavailability and low toxicity [23]. Polydispersity leads to a larger size distribution, which interferes with the tendency for the nanocarrier to accumulate in the target tissue [23].
Polydispersity describes the degree of non-uniformity of size distribution between molecules due to the aggregation or agglomeration of the polymeric network. It can be estimated using the polydispersity index (PDI), where the ideal index for chitosan nanoparticles is below 0.3 [22, 23]. The degree of deacetylation and molecular weight of chitosan have been proven to influence the polydispersity of the system [24].
PDI increases with an increase in molecular weight. However, it decreases as the degree of deacetylation increases [23]. The increase of amino group protonation and removal of the acetyl group from chitosan structure lead to the enhancement of repulsive forces between molecules and stretch the chitosan to become larger in size [11, 24]. Therefore, the development of chitosan with the optimum degree of deacetylation is needed to minimise the risk of polydispersity. This can be achieved by modifying the time and temperature of the de-
The degree of entanglement for HMWC nanoparticles is higher than LMWC. Therefore, HMWC nanoparticle has a high tendency to aggregate with each other and disrupt the uniformity of the system [25]. However, LMWC cannot be loaded into nanoparticles with smaller size due to its limitation to entangle to the structures of the system [26]. Therefore, maintaining the particle size of the chitosan is crucial in the development of a chitosan nanoparticle.
Modified chitosan shows greater advantages as compared to unmodified chitosan. The modification of chitosan either chemically or physically may improve its solubility, properties of gelling, and biocompatibility. This modification can be done through cross-linking or substitution [27]. The presence of the various reactive functional groups in the chitosan structure makes it available in many derivatives with different stability properties.
A quaternary ammonium salt is a hydrophilic group with a permanent positive charge. Therefore, quaternary chitosan does not need an acidic condition to undergo protonation [12, 28]. It allows chitosan quaternary ammonium salts to be soluble in both acidic and basic pH. This is a good approach to increase chitosan solubility in water [28].
The high strength of the positive charge will weaken the hydrogen bond. However, this activity depends on the degree of substitution. The higher the degree of substitution, the higher the water solubility of chitosan. This will improve the quality of chitosan to act as a mucoadhesive agent that aids the penetration into mucus [29].
Trimethyl chitosan (TMC) is an example of a chitosan derivative from quaternisation. This modification is effective in enhancing the bioavailability of antibacterial drugs with antibacterial properties. Moreover, quaternised chitosan also exhibits antibacterial properties by the interaction of its positive charge with the negative charge of Gram-negative bacteria [28, 29, 30].
Sulfonated chitosan is water-soluble anionic chitosan, which was derived with N-benzyl disulfonated derivative [31]. This modification of chitosan has been shown to be effective, not only as antiviral and antibacterial but also as anticoagulant properties. Sulfonated chitosan interferes with the interaction between the envelope glycoprotein (gp120) and its receptor on the CD4 cells’ surface. Therefore, It inhibits the replication of HIV [32].
Sulfonated chitosan has been developed to carry anticoagulant drugs such as reviparin and enhance the anticoagulant activity. Sulfonated chitosan nanoparticles interact with factor Xa and inhibit their function in the blood clotting mechanism [31, 33]. Low molecular weight sulfoethyl chitosan acts as capping of nanoparticles [33]. A capping agent is needed in the nanoparticulate system to prevent agglomeration.
Amphotericin B is used to treat fungal infection by binding to ergosterol on the cell membrane of fungal. It depolarises the membrane and alters its permeability [34]. Sulfonated chitosan has been used in the formulation of amphotericin B to reduce the side effects of the drug by making sure the drug specifically targets the ergosterol of fungal [35].
The structure of mucin that coats the intestinal epithelial cell contains the cysteine-rich domain. This domain easily forms a disulfide bond with a thiolated derivative of chitosan. The bond formations increase the residence time for the chitosan to the mucus and increase the mucoadhesive property of the chitosan [30, 36]. When chitosan covalently bonded with any thiolated moiety, water-soluble carbodiimide is required as a cross-linker [30]. Carbodiimide increases the number of thiol groups. This enhances the immobilisation phenomena, which is the formation of disulfide bonds due to the activation of carboxylic groups.
The thiolation of TMC with the conjugation of cysteine residue increases the strength of covalent bonding between mucin. The covalent bond formation of chitosan with thioglycolic acid (TGA) is an effective carrier in delivering trimethoprim for urinary tract infection [37]. The preparation of chitosan-TGA nanoparticles should be stabilised by covalent cross-linking with polyanion, such as tripolyphosphate [38]. The cross-linking minimise the risk of particle aggregation, increases the disulfide bond, and strengthens the mechanical force between networks, which allows trimethoprim to be released slowly [37].
The conjugation of chitosan with glutathione will protect peptide drugs from aminopeptidase in the GIT [39]. Glutathione has thiol groups which exhibit strong electron-donating properties. It forms an α-peptide bond with cysteine moiety of aminopeptidase [30]. Glutathione also acts as an antioxidant which reduces oxidative stress and increases the adhesion of formulation to the cell [30].
The poor water solubility of chitosan makes them less effective as a permeation enhancer. The addition of the carboxyalkyl group will transform the molecule into amphoteric in nature and allow them to react in both basic and acidic conditions [40]. The interaction between the carboxyl group and the primary amino group of chitosan exhibits a promising approach in developing controlled drug release.
The Schiff base reactive gives rise to the formation of the N-carboxymethyl derivative of chitosan [41]. This modification of chitosan has been shown to improve the absorption of low molecular weight heparin (LMWH). After coating into polydopamine, the conjugation of LMWH with carboxymethyl chitosan into polyurethane substrate shows excellent hemocompatibility of heparin. This modification enhances the bioavailability and improves the anticoagulant effect of heparin [42].
Propranolol hydrochloride has a short half-life and requires every 6 to 8 hours in a divided daily dose. The use of carboxymethyl chitosan will coat the drug with a polymer matrix. It controls the release of drug with zero-order kinetics, allowing the constant amount of drug will be eliminated per unit time. The hydration of carboxymethyl chitosan will form a gel layered around the drug, which essential in drug release [43, 44].
The release of drugs from the chitosan nanoparticle is influenced by the hydrophilicity of chitosan and pH of the swelling solution. Chitosan release mechanism involves swelling, diffusion of drugs through the polymeric matrix and polymer erosion [45]. Due to the hydrophilicity of chitosan, chitosan nanoparticles exhibit pH-dependent drug and controlled drug release system [6].
Acid and base act as catalysts in the degradation of polymers [46]. Therefore, the behaviour of swelling and the amount of drug released is highly dependent on the pH of the swelling solution. Hence, a modified drug release can be achieved [46]. When polymers get into contact with an aqueous medium, the water will diffuse into the polymer until the polymer swells (Figure 3).
The swelling of swellablepolymers in aqueous medium (adapted from [
The polymeric chitosan chain will start to detangle. The swelling polymer will form pores which allow drugs to diffuse out of the nanoparticulate system [6, 43, 47]. Therefore, the water solubility of chitosan is crucial in the mechanism of drug release from the nanoparticulate system.
Oral drug administration is the most convenient route, especially among the elderly and children. Unfortunately, some drugs and vaccines cannot withstand the physiological barrier of GIT. In the presence of mucus, proteolytic enzymes, and first-pass metabolism by the liver, drugs tend to be degraded or converted into inactive metabolites [48]. Some drugs will be excreted in the urine lead to low bioavailability.
Due to the challenges aforesaid, chitosan and its derivatives have been used in the development of nanotechnology to improve oral drug delivery [25, 30]. It encapsulates drugs to protect them from degradation in the GIT environment. As a consequence of its excellent biodegradable, biocompatibility, and non-toxic properties, chitosan promotes a stimuli-responsive release of drugs. It allows active ingredients to be released from the formulation in a controlled manner, specifically in enteric-coated drugs [38, 43].
Due to its antimicrobial properties, it was used in the delivery of oral antibiotics to eradicate Gram-negative bacteria such as
A peptide is made up of short polymers of ⍺-amino acid, which is around 20 to 50 amino acids. The function of small peptides depends on the functional group of various amino acids. Examples of active peptides are glutathione, bradykinin, angiotensin, vasopressin and oxytocin [4].
Protein is a macromolecular and high molecular weight polypeptide, which is made up of long-chain amino acids (more than 50) arranged in a linear chain through peptide bonds [50]. It can exist in four different structural conformations such as primary, secondary, tertiary, and quaternary. The formation of these structures is dependent on the intermolecular interaction between functional groups of amino acids [51], through covalent bonds or non-covalent bonds.
The covalent bonds are strong bonds which include peptide bonds and disulfide bonds [51]. Peptide bonds are interactions between two consecutive amino acids through amino and carboxyl groups. Meanwhile, disulfide bonds link two cysteine residues through sulphhydryl groups [52].
On the other hand, non-covalent bonds are weak bonds that include hydrogen, electrostatic and hydrophobic bonds. Hydrogen bonds link two different peptides with the hydrogen atom of the N-H group and oxygen of the carboxylic group. Hydrophobic bonds will occur if the hydrophobic nature between non-polar side chains of amino acid interacts with each other [51].
The physiological barriers in the GIT responsible for protecting the body from the entry of pathogens. These barriers may reduce the bioavailability of the protein. The barriers aforesaid include biochemical, cellular, and mucus barriers (Figure 4) [53].
Physiological barriers to oral protein and peptide delivery (adapted from [
The entire GIT has been coated with mucus. Mucus also promotes a physical barrier between the lining of epithelial and lumen [54]. It contains mucin protein which secretes proteolytic enzymes and traps peptide drugs through electrostatic interaction [55].
The epithelium of the GIT consists of an intestinal epithelial stem and microfold cells (M-cell) [48]. These cells are responsible for controlling protein uptake from the gut lumen into the bloodstream. Since protein drug is a macromolecule, the presence of protein complexes between adjacent epithelial cells prevents paracellular transport of drug [56]. Meanwhile, transcellular transport is limited only to highly lipophilic molecules, unless the transportation is mediated by P-gp [57].
Due to the physical and chemical instability of protein in the GIT, they would not achieve an acceptable therapeutic bioavailability. The nature of the GIT as great physiology to digest food will be a barrier for protein drugs to penetrate through the membrane. The challenges and strategies to improve the protein drug delivery through oral administration need to be considered to ensure the drug achieves adequate therapeutic concentration in the body [58].
GIT is the hollow organs include the oral cavity, stomach, small intestine, large intestine, and colon. Each part of the GIT is varying in pH. However, most proteins are stable at neutral pH and tend to undergo protein denaturation at the extreme changes in pH [48]. A building block of protein is sensitive to pH. In the presence of hydrochloric acid in the stomach, hydrolysis will occur and the disulphide bonds of peptide will be reduced.
Acidic pH environment activates the conversion of pepsinogen into pepsin [59], by transferring hydrogen ion (H+). Pepsin is responsible for the breakdown of peptide bonds which will interfere with the structure and stability of the peptide [59].
In the small intestine, the pancreatic juice is secreted in the duodenum. This juice contains pancreatic enzymes and bicarbonate ions (HCO3−) [48]. The pancreatic enzymes consist of amylase, lipase, and protease, which are responsible for the digestion of lipid and peptide. Protease catalyses the proteolysis rate, which cleaves peptide bonds through hydrolysis [4, 58].
The presence of chymotrypsin and peptidase in the jejunum interferes with peptide absorption in the epithelial membrane [48]. Peptide drugs are digested before it reaches the membrane and the fraction of the undigested peptide will reduce. This physiological function will lower the possibility for the therapeutic concentration of peptides to be achieved in the systemic circulation [58].
The layers of the epithelial cell of the intestine are covered by mucus or mucin glycoproteins [55]. These glycoproteins will form a gel layer that covers the surface of the intestinal cell. The diffusion rate for the peptide to the epithelial membrane is restricted in the presence of mucus [54].
One of the intestinal mucosal epithelial cells is the goblet cell. Goblet cells are responsible for secreting mucin 2 in the intestine and Mucin-5b in the colon. Lubricate the passage for chime is the main function of the mucus layer, protecting the epithelium from mechanical damage of GIT [54].
The overexpression of mucin will interfere with the pharmacokinetics of drugs. The higher the concentration of the mucin, the lower the ability of a drug to diffuse through the membrane. Drugs and mucin interact through hydrophobic and Van der Waals interaction.
Large amounts of enzymes present within the mucus layer increase the tendency to digest peptide drugs [58]. The ionic strength, pH, and chyme content in the intestine will affect the charge density in the mucin [54]. The presence of a charged group on mucin interact ionically with charged particles and immobilised them in the mucus. The immobilisation of peptides leads to the clearing from the tract when the layer of mucus is shed [60].
Tight junctions are protein complexes that existed within the adjacent epithelial cells [48]. It prevents leakage and restricts the flux of substances through the paracellular pathway [61]. They consist of transmembrane protein with extracellular domains called Claudin 4 (CLDN4). CLDN4 protects the paracellular physiological function of GIT [62].
The linkage of CLDN4 domains with zonula occludens 1 will result in the connection of cytoskeleton components through linker protein [62]. The components include actin, myosin and microtubules which involve in the contraction of muscle, upon phosphorylation. The contraction leads to cellular tightness, hence, reduce the permeability of substance into the cell.
The effective delivery of oral peptide drugs can be achieved by altering the formulation for maximum solubility, avoid enzymatic degradation and enhance the absorption of drugs through the intestinal epithelial cell [63]. For the sake of preventing enzymatic degradation or inactivation, the addition of enzyme or protease inhibitor is a great approach (Figure 5). Proteolytic enzymes are responsible for cleaving protein molecules into an inactive amino acid chain. Protease inhibitors such as aprotinin and chromostatin can be used to prevent the inactivation of protein drugs [7].
Strategies to improve oral peptide delivery system (adapted from [
As discussed earlier, protein molecules show poor permeability through various mucosal surfaces and biological membranes. The improvement of membrane permeability can be achieved by the inclusion of a permeation enhancer into the formulation. Permeation enhancers are either tight junction selective or membrane perturbing [61].
Chitosan and its derivatives have been used as an enzyme inhibitor, permeation enhancer and mucoadhesive agent [30]. With the different mechanism, modification, and preparation technique, this polymer also involves in the encapsulation of peptide drugs into the nanoparticulate system [60], which protect them from harsh GIT environment.
There are two types of protease, including serine protease and Zn2+-dependent protease. Serine proteases, such as trypsin, chymotrypsin and elastase are pancreatic digestive enzymes. Meanwhile, Zn2+-dependent protease such as matrix metalloproteinase is an insulin-degrading enzyme [64]. Some enzyme inhibitors need chitosan to enhance their anti-protease activity and minimise peptide drug degradation [64]. For example, chymostatin is a protease inhibitor selectively to chymotrypsin-like serine proteases. This inhibitor will covalently be linked to the amino group of chitosan.
The active site of matrix metalloproteinase, such as carboxypeptidase, contains Zn2+ binding motif. It requires Zn2+ to promote nucleophilic attack by water. This protease cleaves membrane-bound pre-proteins of the cell to release cytokine. The ethylenediaminetetraacetic acid (EDTA) is a complexing agent that is capable of forming a complex with Zn2+ and retard the nucleophilic attack of water on carboxypeptidase. To inhibit the Zn2+-dependent protease, the EDTA is covalently bound to the primary amino groups of the chitosan-inhibitor conjugate [27, 65].
Moreover, the study showed that the effect of trypsin inhibitors would be disrupted after the gastric phase. Therefore, the encapsulation of the peptide drug and trypsin inhibitor with chitosan-EDTA conjugates improve the controlled release of the molecules.
Chitosan derivatives improve the permeation of water-soluble drug molecules due to their ability to adhere to the mucus [30]. Thiolated chitosan shows a greater effect in improving drug permeation through the cell membrane. With the formation of disulfide bridges, the thiol group of chitosan interacts with the cysteine-rich subdomains of mucus and allows greater mucoadhesion. Thus, the absorption of the peptide drug molecule increases with residence time [30].
It is worth noting that chitosan with a low degree of acetylation and high molecular weight leads to high charge density. The higher positive charge density of chitosan will bind to negatively charged tight junction channels. Ion displacement occurs, leading to intracellular spaces loosening [16].
The integrity and permeability of tight junctions can be illustrated with transepithelial electrical resistance (TER). The ability of TMC [66] and carboxymethyl chitosan [67] in decreasing the TER will increase the permeability of peptide drugs. TMC has been used to formulate buserelin, a synthetic peptide analogue for LHRH agonist, by the oral delivery system [68].
Thiolated chitosan, such as glutathione, cysteine and N-acetylcysteine, have strong mucoadhesive properties due to covalent bonding with cysteine-rich subdomains of the mucus glycoprotein. For chitosan-glutathione, this derivative improves chitosan stability, enhanced mucoadhesion and permeation enhancing effect. This system has been applied to the oral delivery of immunostimulant drug, thymopentin [30].
Chitosan-cysteine shows similar mucoadhesive but improved cohesion as compared to unmodified chitosan. The cohesiveness of polymeric drug formulation is crucial to ensure the stability of the drug and will be released in a controlled manner. Furthermore, chitosan-N-acetylcysteine produces a longer retention time than unmodified chitosan. However, no drugs have been tested yet for these two chitosan derivatives [30].
By encapsulating peptides into a nanoparticulate system, enzymolysis and peptide aggregation can be avoided. This approach enhances the absorption of peptide drugs through the transmembrane of the small intestinal epithelium [69]. Nanoparticle will provide controlled-release properties in the presence of chitosan as a polymer. This condition will reduce repetitive dose administration and improve drug bioavailability [43]. In the presence of chitosan as a mucoadhesive agent, the retention time between formulation and absorption site will be maximised.
Cyclosporine is a cyclic peptide drug used to suppress the immune system, after organ transplantation. Cyclosporine with high molecular weight (1.32 kDa) shows poor bioavailability with low permeability through the biological barrier. Conventional oral cyclosporine has been shown to have an unpredictable low therapeutic concentration in the bloodstream.
Therefore, a nanoparticle drug delivery system is a promising strategy to improve the oral bioavailability of cyclosporine. Chitosan nanoparticles in the presence of tripolyphosphate, as a cross-linker, make it more convenient as compared to conventional ones. The bioavailability of the nanoparticulate cyclosporine increases by 73% [69]. Exendin-4 is a glucagon-like peptide-1 receptor agonist that has been approved to control type 2 diabetes mellitus. This peptide drug has high susceptible to enzymatic degradation [70]. Chitosan-tripolyphosphate conjugated nanoparticle was used to design oral suspension and enteric-coated capsules of exendin-4 to increase the bioavailability of exendin-4 slightly.
Efflux pump is a membrane protein located within the cytoplasmic membrane of a cell. It translocates a variety of substrates across extra- and intra-cellular membranes. Multidrug efflux pump can be one of the drug resistance mechanisms, as it pumps foreign substances (or drugs) out of cells. This active process is an ATP-dependent [71].
P-glycoprotein (P-gp) is a transmembrane glycoprotein and the best example of a multidrug efflux pump. It is expressed and located in the intestinal epithelium, liver cells and proximal tubule cells of the kidney. P-gp is also located within the blood–brain barrier (BBB), which provides an obstacle for drugs to enter the region. Therefore, it must be difficult for antipsychotic drugs to bypass BBB and exert their effect [57, 71, 72].
Chitosan may enhance drug permeation by opening of tight junctions which is highly related to CLDN4 [73]. Chitosan will modulate CLDN4 protein redistribution to the cytosol and disrupt tight junctions [62]. This phenomenon will enhance paracellular permeability and reduce TER. Thus, declining barrier function of epithelial cells to allow drugs to enter the cell [74].
Furthermore, the use of thiolated chitosan (thiomer) has shown to be useful in bypassing the P-gp. The thiol-moiety of thiolated chitosan may allow the formation of disulfide bonds between the cysteine groups of the P-gp [9]. The thiomers then enter the channels of the P-gp pump together with the therapeutic agent, which obstruct the function of the multidrug efflux pump [57].
For infectious disease by Gram-negative bacteria, chitosan plays an important role in facilitating effective delivery of antimicrobials to the infection site [15, 49]. Chitosan will encapsulate drugs and carry them into bacterial cells by attraction forces between polycationic chitosan and negatively charged bacteria [49]. This action avoids the efflux pump at the cell membrane of the bacterial cell.
Vaccination is one of the most cost-effective approaches to prevent infectious diseases such as hepatitis B, tetanus, polio, and rabies. Vaccines contain pathogens, either live-attenuated, inactive or killed antigen [75]. These pathogens will be administered in the body and recognised by the immune system.
The oral delivery of vaccines is quite challenging as the pathogen is introduced into the body. It is mandatory to ensure mucosal immune response works effectively to protect the body against the pathogen and their toxin [54].
As the vaccine enters the intestine, its presence will trigger the inductive site, the Peyer’s patches. The Peyer’s patches consist of M-cell which will allow the entry of the antigen through endocytosis. The antigen then will be transported into intraepithelial dendritic cells or macrophages and be taken up by the cell through phagocytosis [76].
The antigen-loaded dendritic cell will present the antigen fragment on its surface and triggers the activation of naive CD4+ T-cells. The activated CD4+ T-cells will bind to the antigen fragment, MHC class II. This binding releases chemical mediators, interleukin-2 (IL-2), that function to regulate the activity of lymphocytes for immunity. IL-2 stimulates the cell division of CD4+ T-cells, activates B-cells and cytotoxic T-cells. B-cell is responsible for mediating humoral immunity by differentiating into plasma cells. Plasma cells will generate antibodies to fight against pathogens [77].
Viral protein requires the right structural conformation to attach to the host cell and replicate. Highly acidic in the stomach and extreme temperature changes will cause protein denaturation. The denaturation of the virus will alter the conformation of its structure [58]. The high temperature will break the phosphodiester bond. However, at low temperature, the degradation of the nucleic acid will also lead to viral inactivation [78].
Furthermore, to transport vaccines orally, it should be able to overcome the biological barrier of the intestinal epithelial cell such as tight junction and mucus. The hydrophilic antigen cannot cross the phospholipid bilayer to enter systemic circulation due to the function of tight junction in controlling the permeability of the membranes. Therefore, the uptake of the antigen to mucosal tissue is limited with a short time of exposure [78].
The GIT contains normal flora or microbiota which help in maintaining the structure of the gut mucosal barrier [55]. Those microbiotas not only aid nutrient metabolism, but they also possess an action to protect against invading pathogens [79, 80]. Well-balance microbiota is needed to induce the effectiveness of vaccines through oral administration. The delivery of the vaccine will be interrupted in patients with microbiota dysbiosis, leading to blunted vaccine response [80].
The induction of danger signals appropriately by the vaccine is essential to trigger an immune response [81]. Due to these limitations, there is a problem in inducing an adequate immune response against administered pathogens [3]. Consequently, a higher and repetitive dose is required. Nevertheless, the administration of high antigen doses repetitively may develop systemic oral tolerance towards vaccines [3, 78].
The uptake of antigen by immune cells depends on the particle size of the antigen. The smaller size of pathogens is readily taken up by dendritic cells [75]. The same goes for peptide, encapsulation of pathogens in nanoparticles is a good approach to improve the effectiveness of vaccines in stimulating the immune system [75].
Small particle size is required to penetrate the mucus. The formulation will be excluded out from the layer of mucus if particle size greater than normal mucus pore size (100–500 nm). This leads to the interruption in the bioavailability of antigen to targeted antigen-presenting cell (APC). Therefore, the development of nanoparticulate systems is required to provide a smaller size (20 – 40 nm) of formulation [82].
Medium molecular weight chitosan (MMWC) with the degree of deacetylation of 85% has been shown to improve the delivery of ovalbumin antigen with the presence of alginate and calcium phosphate (CaP). CaP has adjuvant properties by activating the surface expression of B-cell. CaP can be coated with mucosal penetrating polymers, such as chitosan and alginate to avoid biodegradation by enzymes present in the GIT [82]. In the stomach, the alginate-chitosan-coated CaP nanoparticle delays the release of ovalbumin antigen. The antigen then will be released in the intestine and colon with a sustained-release mechanism. This nanocarrier has successfully encapsulated ovalbumin antigen with small size (< 50 nm) [82].
The antigen should be transported to the intestine and directly to the M-cell of the Peyer’s patches [6]. Chitosan develops well-protected mucoadhesion by prolonging the residence time at mucosal surfaces. The uptake of antigen by epithelial cells of the intestine will be improved by chitosan. An increase in the activity of macrophages will improve the secretion of mucosal IgA and IgG [76].
Chitosan-based drug formulation has gained attention for their ability to serve as a carrier and an enhancer for oral delivery of peptides and vaccines. Although oral delivery is the most convenient and preferred route of administration, however, it has limitations due to the presence of the proteolytic enzyme, pH of GIT and the intestinal barrier to drug absorption. In recent years, there has been considerable research interest in the application of chitosan as an enzyme inhibitor, mucoadhesive agent and efflux pump inhibitor. Interaction of positively-charged amino groups of chitosan with negatively-charged sialic acid groups that exist in mucin prolongs the residence time between drugs and membranes, therefore enhancing the bioavailability of the drugs. Other formulation strategies include encapsulation of proteins, peptides and vaccines into a nanoparticulate delivery system. By encapsulating peptide into a nanocarrier system, the enzymolysis and peptides aggregation can be avoided thus enhances the absorption of peptide drugs in the intestinal epithelium. Similarly, encapsulation of pathogens in nanoparticles is a good approach to improve the effectiveness of vaccines in stimulating the immune system.
The authors acknowledge Faculty of Pharmacy, Universiti Teknologi MARA and internal grant (DUCS) 2.0, 600-UiTMSEL (PI. 5/4) (016/2020).
The authors declare no conflict of interest.
Kilodalton Nano-metre Gastrointestinal tract Gibbs free energy Polydispersity index Low molecular weight chitosan High molecular weight chitosan Medium molecular weight chitosan Trimethyl chitosan Transcellular electrical resistance Thioglycolic acid Low molecular weight heparin P-glycoprotein Claudin 4 Ethylenediaminetetraacetic acid Interleukin-2 Antigen-presenting cell Calcium phosphate Polyethylene glycol Pegylated chitosan Hydroxypropyl methylcellulose phthalate
Ove Odredbe i uvjeti ističu pravila i regulacije u svezi korištenja IntechOpenove stranice www.intechopen.com i svih poddomena u vlasništvu IntechOpena, tvrtke sa sjedištem u 5 Princes Gate Court, London, SW7 2QJ, Ujedinjeno Kraljevstvo.
',metaTitle:"Odredbe i uvjeti",metaDescription:"Ove Odredbe i uvjeti ističu pravila i regulacije u svezi korištenja IntechOpenove stranice www.intechopen.com i svih poddomena u vlasništvu IntechOpena, tvrtke sa sjedištem u 5 Princes Gate Court, London, SW7 2QJ, Ujedinjeno Kraljevstvo.",metaKeywords:null,canonicalURL:"/page/cro-terms-and-conditions",contentRaw:'[{"type":"htmlEditorComponent","content":"Pristupom na stranicu www.intechopen.com slažete se s ovim odredbama, sa svim primjenjivim zakonskim odredbama, te se slažete s poštovanjem svih lokalnih zakona. Korištenje i/ili pristup ovoj stranici temelji se na potpunom prihvaćanju ovih odredbi. Svi materijali na ovoj stranici zaštićeni su primjenjivim zakonima o autorskim pravima i žigu.
\\n\\nSljedeća terminologija odnosi se na Odredbe i uvjete, te na sve naše ugovore:
\\n\\nKlijent, stranka, vi, vaš odnosi se na vas, osobu koja pristupa ovoj stranici i prihvaća IntechOpenove Odredbe i uvjete;
\\n\\nKompanija, tvrtka, mi, naše odnosi se na tvrtku IntechOpen;
\\n\\nStranke, strane odnosi se na klijenta i na nas, ili samo na klijenta ili nas.
\\n\\nSve odredbe koje se odnose na ponudu, prihvat ili razmatranje plaćanja, a za koja mi pružamo asistenciju klijentu, bilo na ugovoreni ili fiksni način, a s ciljem da se ostvare potrebe i želje klijenta u svezi s našim uslugama, su podložne zakonskim odredbama Ujedinjenog Kraljevstva.
\\n\\nOsim ako nije suprotno navedeno, IntechOpen i/ili svi davatelji licence vlasnici su intelektualnog vlasništva nad svim materijalima na www.intechopen.com. Sva prava intelektualnog vlasništva su pridržana. Stranice sa www.intechopen.com možete gledati, preuzimati, dijeliti, dijeliti poveznice i printati za osobnu uporabu, a temeljem pravila sadržanih u ovim Odredbama i uvjetima.
\\n\\nMi koristimo kolačiće. Korištenjem IntechOpenove stranice slažete se s korištenjem kolačića u skladu s IntechOpenovom Politikom privatnosti. Većina modernih, interaktivnih stranica koristi kolačiće kako bi omogućila ponovno pronalaženje korisničkih detalja kod svakog posjeta. Na našoj stranici kolačići se uglavnom koriste kako bi omogućili funkcionalnost i olakšali posjetiteljima korištenje stranice.
\\n\\nIntechOpen ili njegovi suradnici niti u jednom slučaju neće biti odgovorni za štete (štete uključuju gubitak podataka ili profita, druge poslovne prekide, te sve ostale štete) koje nastanu zbog korištenja materijala na IntechOpenovoj stranici ili nemogućnosti da se iste koriste, čak i ako je IntechOpen ili njegov predstavnik o takvoj šteti obaviješten pismenim ili usmenim putem. Neke jurisdikcije ne dozvoljavaju ograničenja garancija ili ograničenja obveza za posljedične ili slučajne štete pa se u tom slučaju ova ograničenja možda ne odnose na vas.
\\n\\nMaterijali koji se pojavljuju na IntechOpenovoj stranici mogu sadržavati manje greške, tipfelere ili fotografske greške. IntechOpen može napraviti promjene na bilo kojem materijalu koji se nalazi na stranici u bilo koje vrijeme.
\\n\\nIntechOpen nije formalno povezan niti s jednom vanjskom stranicom čije poveznice vode na www.intechopen.com, osim ako to nije izravno navedeno. Iz tog razloga IntechOpen nije odgovoran za sadržaj koji se pojavljuje na takvim stranicama. Poveznica na IntechOpenovu stranicu ne implicira povezanost sa IntechOpenom. Korištenje takvih poveznica isključiva je odgovornost korisnika.
\\n\\nZadržavamo pravo vlasništva nad cjelokupnom stranicom www.intechopen.com i nad svim materijalom na toj stranici. Koristeći se našim uslugama, slažete se da maknete sve poveznice na našu stranicu odmah nakon što to od vas zatražimo. Također, zadržavamo pravo da ove Odredbe i uvjete, i politiku o poveznicama izmjenimo u bilo koje vrijeme. Koristeći se poveznicama na naše stranice slažete se s ovim Odredbama i uvjetima.
\\n\\nAko smatrate da je bilo koja poveznica na našoj stranici sumnjiva iz bilo kojeg razloga, molimo vas da nas kontaktirate. U tom slučaju razmotrit ćemo micanje poveznice s naše stranice, iako nismo obvezni to napraviti.
\\n\\nBez prethodne privole i izričite pisane dozvole, ne možete stvarati okvire oko naših stranica ili koristiti druge tehnike koje na bilo koji način mogu promijeniti prezentaciju ili izgled naše stranice.
\\n\\nIntechOpen može ove Odredbe izmijeniti u bilo koje vrijeme i bez prethodne obavijesti. Koristeći ovu stranicu vi se slažete s trenutnim Odredbama i uvjetima koje su na snazi.
\\n\\nOve Odredbe i uvjeti su sastavljeni u skladu s odredbama prava Ujedinjenog Kraljevstva, a za sve sporove nadležan je sud u Londonu, Ujedinjeno Kraljevstvo.
\\n"}]'},components:[{type:"htmlEditorComponent",content:"Pristupom na stranicu www.intechopen.com slažete se s ovim odredbama, sa svim primjenjivim zakonskim odredbama, te se slažete s poštovanjem svih lokalnih zakona. Korištenje i/ili pristup ovoj stranici temelji se na potpunom prihvaćanju ovih odredbi. Svi materijali na ovoj stranici zaštićeni su primjenjivim zakonima o autorskim pravima i žigu.
\n\nSljedeća terminologija odnosi se na Odredbe i uvjete, te na sve naše ugovore:
\n\nKlijent, stranka, vi, vaš odnosi se na vas, osobu koja pristupa ovoj stranici i prihvaća IntechOpenove Odredbe i uvjete;
\n\nKompanija, tvrtka, mi, naše odnosi se na tvrtku IntechOpen;
\n\nStranke, strane odnosi se na klijenta i na nas, ili samo na klijenta ili nas.
\n\nSve odredbe koje se odnose na ponudu, prihvat ili razmatranje plaćanja, a za koja mi pružamo asistenciju klijentu, bilo na ugovoreni ili fiksni način, a s ciljem da se ostvare potrebe i želje klijenta u svezi s našim uslugama, su podložne zakonskim odredbama Ujedinjenog Kraljevstva.
\n\nOsim ako nije suprotno navedeno, IntechOpen i/ili svi davatelji licence vlasnici su intelektualnog vlasništva nad svim materijalima na www.intechopen.com. Sva prava intelektualnog vlasništva su pridržana. Stranice sa www.intechopen.com možete gledati, preuzimati, dijeliti, dijeliti poveznice i printati za osobnu uporabu, a temeljem pravila sadržanih u ovim Odredbama i uvjetima.
\n\nMi koristimo kolačiće. Korištenjem IntechOpenove stranice slažete se s korištenjem kolačića u skladu s IntechOpenovom Politikom privatnosti. Većina modernih, interaktivnih stranica koristi kolačiće kako bi omogućila ponovno pronalaženje korisničkih detalja kod svakog posjeta. Na našoj stranici kolačići se uglavnom koriste kako bi omogućili funkcionalnost i olakšali posjetiteljima korištenje stranice.
\n\nIntechOpen ili njegovi suradnici niti u jednom slučaju neće biti odgovorni za štete (štete uključuju gubitak podataka ili profita, druge poslovne prekide, te sve ostale štete) koje nastanu zbog korištenja materijala na IntechOpenovoj stranici ili nemogućnosti da se iste koriste, čak i ako je IntechOpen ili njegov predstavnik o takvoj šteti obaviješten pismenim ili usmenim putem. Neke jurisdikcije ne dozvoljavaju ograničenja garancija ili ograničenja obveza za posljedične ili slučajne štete pa se u tom slučaju ova ograničenja možda ne odnose na vas.
\n\nMaterijali koji se pojavljuju na IntechOpenovoj stranici mogu sadržavati manje greške, tipfelere ili fotografske greške. IntechOpen može napraviti promjene na bilo kojem materijalu koji se nalazi na stranici u bilo koje vrijeme.
\n\nIntechOpen nije formalno povezan niti s jednom vanjskom stranicom čije poveznice vode na www.intechopen.com, osim ako to nije izravno navedeno. Iz tog razloga IntechOpen nije odgovoran za sadržaj koji se pojavljuje na takvim stranicama. Poveznica na IntechOpenovu stranicu ne implicira povezanost sa IntechOpenom. Korištenje takvih poveznica isključiva je odgovornost korisnika.
\n\nZadržavamo pravo vlasništva nad cjelokupnom stranicom www.intechopen.com i nad svim materijalom na toj stranici. Koristeći se našim uslugama, slažete se da maknete sve poveznice na našu stranicu odmah nakon što to od vas zatražimo. Također, zadržavamo pravo da ove Odredbe i uvjete, i politiku o poveznicama izmjenimo u bilo koje vrijeme. Koristeći se poveznicama na naše stranice slažete se s ovim Odredbama i uvjetima.
\n\nAko smatrate da je bilo koja poveznica na našoj stranici sumnjiva iz bilo kojeg razloga, molimo vas da nas kontaktirate. U tom slučaju razmotrit ćemo micanje poveznice s naše stranice, iako nismo obvezni to napraviti.
\n\nBez prethodne privole i izričite pisane dozvole, ne možete stvarati okvire oko naših stranica ili koristiti druge tehnike koje na bilo koji način mogu promijeniti prezentaciju ili izgled naše stranice.
\n\nIntechOpen može ove Odredbe izmijeniti u bilo koje vrijeme i bez prethodne obavijesti. Koristeći ovu stranicu vi se slažete s trenutnim Odredbama i uvjetima koje su na snazi.
\n\nOve Odredbe i uvjeti su sastavljeni u skladu s odredbama prava Ujedinjenog Kraljevstva, a za sve sporove nadležan je sud u Londonu, Ujedinjeno Kraljevstvo.
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6597},{group:"region",caption:"Middle and South America",value:2,count:5902},{group:"region",caption:"Africa",value:3,count:2400},{group:"region",caption:"Asia",value:4,count:12537},{group:"region",caption:"Australia and Oceania",value:5,count:1006},{group:"region",caption:"Europe",value:6,count:17560}],offset:12,limit:12,total:132761},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"1",sort:"dateEndThirdStepPublish",topicId:"7,10,15,24,5,6,8,9,11,23,14,16,17,12,18,19,20,21,22,13,25"},books:[{type:"book",id:"11254",title:"Optical Coherence Tomography",subtitle:null,isOpenForSubmission:!0,hash:"a958c09ceaab1fc44c1dd0a817f48c92",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11254.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11472",title:"21st Century Slavery",subtitle:null,isOpenForSubmission:!0,hash:"b341f3fc3411ced881e43ce007a892b8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11472.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11473",title:"Social Inequality",subtitle:null,isOpenForSubmission:!0,hash:"20307129f7fb39aa443d5449acb6a784",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11473.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11546",title:"Smart and Sustainable Transportation",subtitle:null,isOpenForSubmission:!0,hash:"e8ea27a1ff85cde00efcb6f6968c20f8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11546.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11554",title:"Information Systems Management",subtitle:null,isOpenForSubmission:!0,hash:"3134452ff2fdec020663f241c7a9a748",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11554.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11436",title:"Beauty",subtitle:null,isOpenForSubmission:!0,hash:"0e15ba86bab1a64f950318f3ab2584ed",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11436.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11438",title:"Fake News in the Era of Pandemics",subtitle:null,isOpenForSubmission:!0,hash:"bc9e4cab86c76f35cd70b39086d9b69e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11438.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11588",title:"Autism",subtitle:null,isOpenForSubmission:!0,hash:"0c5043c6174db167599cb3f762e8bba8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11588.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11605",title:"Bamboo",subtitle:null,isOpenForSubmission:!0,hash:"378d957561b27c86b750a9c7841a5d18",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11605.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11612",title:"Landraces",subtitle:null,isOpenForSubmission:!0,hash:"06316c41a6f6317ad2bee244dc98c6a4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11612.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11616",title:"Foraging",subtitle:null,isOpenForSubmission:!0,hash:"955b60bb658c8d1a09dd4efc9bf6674b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11616.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11632",title:"Updated Research on Bacteriophages",subtitle:null,isOpenForSubmission:!0,hash:"d34dfa0d5d10511184f97ddaeef9936b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11632.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:43},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:12},{group:"topic",caption:"Business, Management and Economics",value:7,count:8},{group:"topic",caption:"Chemistry",value:8,count:19},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:18},{group:"topic",caption:"Engineering",value:11,count:47},{group:"topic",caption:"Environmental Sciences",value:12,count:7},{group:"topic",caption:"Immunology and Microbiology",value:13,count:12},{group:"topic",caption:"Materials Science",value:14,count:15},{group:"topic",caption:"Mathematics",value:15,count:7},{group:"topic",caption:"Medicine",value:16,count:109},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:2},{group:"topic",caption:"Neuroscience",value:18,count:7},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:11},{group:"topic",caption:"Physics",value:20,count:5},{group:"topic",caption:"Psychology",value:21,count:8},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:32},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:385},popularBooks:{featuredBooks:[],offset:0,limit:12,total:null},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[],latestBooks:[]},subject:{topic:{id:"140",title:"Phenology",slug:"phenology",parent:{id:"12",title:"Environmental Sciences",slug:"environmental-sciences"},numberOfBooks:1,numberOfSeries:0,numberOfAuthorsAndEditors:48,numberOfWosCitations:84,numberOfCrossrefCitations:36,numberOfDimensionsCitations:91,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"140",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"1703",title:"Phenology and Climate Change",subtitle:null,isOpenForSubmission:!1,hash:"38e8c7573556df4f0ebbeff42a93c0ef",slug:"phenology-and-climate-change",bookSignature:"Xiaoyang Zhang",coverURL:"https://cdn.intechopen.com/books/images_new/1703.jpg",editedByType:"Edited by",editors:[{id:"108104",title:"Prof.",name:"Xiaoyang",middleName:null,surname:"Zhang",slug:"xiaoyang-zhang",fullName:"Xiaoyang Zhang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:1,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"32935",doi:"10.5772/39197",title:"Long-Term Detection of Global Vegetation Phenology from Satellite Instruments",slug:"long-term-detection-of-global-vegetation-phenology-from-satellite-instruments-",totalDownloads:3035,totalCrossrefCites:11,totalDimensionsCites:24,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Xiaoyang Zhang, Mark A. Friedl, Bin Tan, Mitchell D. Goldberg and Yunyue Yu",authors:[{id:"108104",title:"Prof.",name:"Xiaoyang",middleName:null,surname:"Zhang",slug:"xiaoyang-zhang",fullName:"Xiaoyang Zhang"}]},{id:"32928",doi:"10.5772/33729",title:"Phenology of Woody Species Along the Climatic Gradient in West Tropical Africa",slug:"phenology-of-woody-species-along-the-climatic-gradient-in-west-tropical-africa-",totalDownloads:2550,totalCrossrefCites:9,totalDimensionsCites:16,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Josiane Seghieri, Frederic C. Do, Jean-Louis Devineau and Anne Fournier",authors:[{id:"96847",title:"Dr.",name:"Josiane",middleName:null,surname:"Seghieri",slug:"josiane-seghieri",fullName:"Josiane Seghieri"},{id:"106913",title:"Dr.",name:"Frederic C.",middleName:null,surname:"Do",slug:"frederic-c.-do",fullName:"Frederic C. Do"},{id:"106915",title:"Dr.",name:"Anne",middleName:null,surname:"Fournier",slug:"anne-fournier",fullName:"Anne Fournier"},{id:"106920",title:"Dr.",name:"Jean-Louis",middleName:null,surname:"Devineau",slug:"jean-louis-devineau",fullName:"Jean-Louis Devineau"}]},{id:"32927",doi:"10.5772/34289",title:"Phenology of Tree Species Populations in Tropical Dry Forests of Southeastern Brazil",slug:"phenological-patterns-of-arboreal-species-in-tropical-dry-forests-in-southeastern-brazil",totalDownloads:2732,totalCrossrefCites:3,totalDimensionsCites:12,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Yule Roberta Ferreira Nunes, Giovana Rodrigues da Luz and Lílian de Lima Braga",authors:[{id:"99523",title:"Prof.",name:"Yule Roberta",middleName:"Ferreira",surname:"Nunes",slug:"yule-roberta-nunes",fullName:"Yule Roberta Nunes"},{id:"107924",title:"MSc.",name:"Giovana",middleName:null,surname:"Rodrigues Da Luz",slug:"giovana-rodrigues-da-luz",fullName:"Giovana Rodrigues Da Luz"},{id:"107925",title:"MSc.",name:"Lílian De Lima",middleName:null,surname:"Braga",slug:"lilian-de-lima-braga",fullName:"Lílian De Lima Braga"}]},{id:"32930",doi:"10.5772/34301",title:"Apple Phenology in Subtropical Climate Conditions",slug:"apple-phenology-in-subtropical-climate-conditions",totalDownloads:4968,totalCrossrefCites:1,totalDimensionsCites:9,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"José Luiz Petri, Fernando José Hawerroth, Gabriel Berenhauser Leite, Marcelo Couto and Poliana Francescatto",authors:[{id:"99575",title:"MSc.",name:"José Luiz",middleName:null,surname:"Petri",slug:"jose-luiz-petri",fullName:"José Luiz Petri"},{id:"136269",title:"Dr.",name:"Fernando José",middleName:null,surname:"Hawerroth",slug:"fernando-jose-hawerroth",fullName:"Fernando José Hawerroth"},{id:"136270",title:"Dr.",name:"Gabriel",middleName:null,surname:"Berenhauser Leite",slug:"gabriel-berenhauser-leite",fullName:"Gabriel Berenhauser Leite"},{id:"136271",title:"Dr.",name:"Marcelo",middleName:null,surname:"Couto",slug:"marcelo-couto",fullName:"Marcelo Couto"},{id:"136272",title:"MSc.",name:"Poliana",middleName:null,surname:"Francescatto",slug:"poliana-francescatto",fullName:"Poliana Francescatto"}]},{id:"32921",doi:"10.5772/36234",title:"Breeding Phenology and Reproductive Strategies in Terrestrial Isopod Species (Crustacea Isopoda Oniscidea) from Tunisia",slug:"breeding-phenology-and-reproductive-strategies-in-terrestrial-isopod-species-crustacea-isopoda-onisc",totalDownloads:5118,totalCrossrefCites:4,totalDimensionsCites:8,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Mohamed Sghaïer Achouri",authors:[{id:"107584",title:"Prof.",name:"Mohamed Sghaïer",middleName:null,surname:"Achouri",slug:"mohamed-sghaier-achouri",fullName:"Mohamed Sghaïer Achouri"}]}],mostDownloadedChaptersLast30Days:[{id:"32924",title:"Phenological Observation in the Czech Republic - History and Present",slug:"phenological-observation-in-the-czech-republic-history-and-present",totalDownloads:2850,totalCrossrefCites:0,totalDimensionsCites:2,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Lenka Hajkova, Jiri Nekovar, Dasa Richterova, Vera Koznarova, Sona Sulovska, Ales Vavra, Alena Vondrakova and Vit Vozenilek",authors:[{id:"101356",title:"Prof.",name:"Vít",middleName:null,surname:"Voženílek",slug:"vit-vozenilek",fullName:"Vít Voženílek"},{id:"103648",title:"Dr.",name:"Lenka",middleName:null,surname:"Hajkova",slug:"lenka-hajkova",fullName:"Lenka Hajkova"},{id:"135954",title:"Dr.",name:"Jiří",middleName:null,surname:"Nekovář",slug:"jiri-nekovar",fullName:"Jiří Nekovář"},{id:"135955",title:"Dr.",name:"Dáša",middleName:null,surname:"Richterová",slug:"dasa-richterova",fullName:"Dáša Richterová"},{id:"135956",title:"Dr.",name:"Věra",middleName:null,surname:"Kožnarová",slug:"vera-koznarova",fullName:"Věra Kožnarová"},{id:"135957",title:"Dr.",name:"Soňa",middleName:null,surname:"Sulovská",slug:"sona-sulovska",fullName:"Soňa Sulovská"},{id:"135958",title:"MSc.",name:"Ales",middleName:null,surname:"Vavra",slug:"ales-vavra",fullName:"Ales Vavra"},{id:"135959",title:"Dr.",name:"Alena",middleName:null,surname:"Vondrakova",slug:"alena-vondrakova",fullName:"Alena Vondrakova"}]},{id:"32934",title:"Correlation of Vegetation and Air Temperature Seasonal Profiles - Spatial Arrangement and Temporal Variability",slug:"correlation-of-vegetation-and-temperature-seasonal-profiles-spatial-arrangement-and-temporal-variabi",totalDownloads:2545,totalCrossrefCites:1,totalDimensionsCites:1,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Simoniello Tiziana, Lanfredi Maria, Coppola Rosa, Imbrenda Vito and Macchiato Maria",authors:[{id:"51545",title:"Dr.",name:"Maria",middleName:null,surname:"Lanfredi",slug:"maria-lanfredi",fullName:"Maria Lanfredi"},{id:"61365",title:"Dr.",name:"Tiziana",middleName:null,surname:"Simoniello",slug:"tiziana-simoniello",fullName:"Tiziana Simoniello"},{id:"61367",title:"Prof.",name:"Maria",middleName:"Francesca",surname:"Macchiato",slug:"maria-macchiato",fullName:"Maria Macchiato"},{id:"107484",title:"Dr.",name:"Rosa",middleName:null,surname:"Coppola",slug:"rosa-coppola",fullName:"Rosa Coppola"},{id:"107501",title:"MSc.",name:"Vito",middleName:null,surname:"Imbrenda",slug:"vito-imbrenda",fullName:"Vito Imbrenda"}]},{id:"32930",title:"Apple Phenology in Subtropical Climate Conditions",slug:"apple-phenology-in-subtropical-climate-conditions",totalDownloads:4972,totalCrossrefCites:1,totalDimensionsCites:9,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"José Luiz Petri, Fernando José Hawerroth, Gabriel Berenhauser Leite, Marcelo Couto and Poliana Francescatto",authors:[{id:"99575",title:"MSc.",name:"José Luiz",middleName:null,surname:"Petri",slug:"jose-luiz-petri",fullName:"José Luiz Petri"},{id:"136269",title:"Dr.",name:"Fernando José",middleName:null,surname:"Hawerroth",slug:"fernando-jose-hawerroth",fullName:"Fernando José Hawerroth"},{id:"136270",title:"Dr.",name:"Gabriel",middleName:null,surname:"Berenhauser Leite",slug:"gabriel-berenhauser-leite",fullName:"Gabriel Berenhauser Leite"},{id:"136271",title:"Dr.",name:"Marcelo",middleName:null,surname:"Couto",slug:"marcelo-couto",fullName:"Marcelo Couto"},{id:"136272",title:"MSc.",name:"Poliana",middleName:null,surname:"Francescatto",slug:"poliana-francescatto",fullName:"Poliana Francescatto"}]},{id:"32927",title:"Phenology of Tree Species Populations in Tropical Dry Forests of Southeastern Brazil",slug:"phenological-patterns-of-arboreal-species-in-tropical-dry-forests-in-southeastern-brazil",totalDownloads:2737,totalCrossrefCites:3,totalDimensionsCites:12,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Yule Roberta Ferreira Nunes, Giovana Rodrigues da Luz and Lílian de Lima Braga",authors:[{id:"99523",title:"Prof.",name:"Yule Roberta",middleName:"Ferreira",surname:"Nunes",slug:"yule-roberta-nunes",fullName:"Yule Roberta Nunes"},{id:"107924",title:"MSc.",name:"Giovana",middleName:null,surname:"Rodrigues Da Luz",slug:"giovana-rodrigues-da-luz",fullName:"Giovana Rodrigues Da Luz"},{id:"107925",title:"MSc.",name:"Lílian De Lima",middleName:null,surname:"Braga",slug:"lilian-de-lima-braga",fullName:"Lílian De Lima Braga"}]},{id:"32928",title:"Phenology of Woody Species Along the Climatic Gradient in West Tropical Africa",slug:"phenology-of-woody-species-along-the-climatic-gradient-in-west-tropical-africa-",totalDownloads:2553,totalCrossrefCites:9,totalDimensionsCites:16,abstract:null,book:{id:"1703",slug:"phenology-and-climate-change",title:"Phenology and Climate Change",fullTitle:"Phenology and Climate Change"},signatures:"Josiane Seghieri, Frederic C. Do, Jean-Louis Devineau and Anne Fournier",authors:[{id:"96847",title:"Dr.",name:"Josiane",middleName:null,surname:"Seghieri",slug:"josiane-seghieri",fullName:"Josiane Seghieri"},{id:"106913",title:"Dr.",name:"Frederic C.",middleName:null,surname:"Do",slug:"frederic-c.-do",fullName:"Frederic C. Do"},{id:"106915",title:"Dr.",name:"Anne",middleName:null,surname:"Fournier",slug:"anne-fournier",fullName:"Anne Fournier"},{id:"106920",title:"Dr.",name:"Jean-Louis",middleName:null,surname:"Devineau",slug:"jean-louis-devineau",fullName:"Jean-Louis Devineau"}]}],onlineFirstChaptersFilter:{topicId:"140",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:287,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:10,numberOfPublishedChapters:103,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"24",title:"Sustainable Development",doi:"10.5772/intechopen.100361",issn:null,scope:"